Novo Nordisk A/S (NVO)
62.47
+0.24
(+0.39%)
USD |
NYSE |
Jan 23, 14:43
Novo Nordisk Price: 62.47 for Jan. 23, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ascendis Pharma A/S | 235.91 |
| Evaxion AS | 4.08 |
| Regeneron Pharmaceuticals, Inc. | 753.84 |
| Omeros Corp. | 12.18 |
| Viking Therapeutics, Inc. | 32.83 |
Price Related Metrics
| PE Ratio | 18.20 |
| PS Ratio | 5.960 |
| PEG Ratio | 1.607 |
| Price to Book Value | 13.69 |
| Price to Free Cash Flow | 30.10 |
| Earnings Yield | 5.50% |
| Market Cap | 277.58B |
| PEGY Ratio | 1.291 |
| Operating PE Ratio | 14.05 |
| Normalized PE Ratio | 18.20 |